Drug Profile
CR 3834
Latest Information Update: 24 Feb 2010
Price :
$50
*
At a glance
- Originator Rottapharm
- Class
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 17 Jun 2005 Preclinical trials in Hypertension in Italy (unspecified route)